Healthcare -
Biotechnology - NASDAQ - US
$ 2.63
3.66 %
$ 12.6 M
Market Cap
-0.31
P/E
PHIO - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities PHIO - Phio Pharmaceuticals Corp.
4 M
LAST VALUE
1147.77%
2 YEAR CAGR
38.93%
5 YEAR CAGR
7.45%
10 YEAR CAGR